Key result
Nonelective TAVR is linked to ~99% higher odds of in-hospital mortality versus elective TAVR.
Why the study?
Nonelective transcatheter aortic valve replacement (TAVR) requires additional research to be fully understood, including its in-hospital outcomes and the impact of transfer status compared with elective TAVR.
Cohort (n=8,778)
Yes
Answers are grounded in this paper and cite their sources.
May inform risk discussions for nonelective TAVR; observational data leave open whether optimized pathways reduce mortality.
Background Nonelective transcatheter aortic valve replacement (TAVR) requires additional research to be fully understood. Methods Using the National Inpatient Sample database (2016-2019), we conducted a retrospective cohort study comparing nonelective vs elective TAVR. The primary outcome of interest was the in-hospital mortality rate among patients undergoing nonelective TAVR, compared to that among patients undergoing elective TAVR. We matched patients in a greedy nearest-neighbor 1:1 model and multivariable logistic regression, which was adjusted for demographics, hospital factors, and comorbidities, and was used to compare mortality in our matched cohort. Results Each cohort had 4389 patients in each cohort. When adjusted for age, race, sex, and comorbidities, nonelective TAVR patients had 1.99 times higher odds of suffering in-hospital mortality compared to elective admissions (adjusted odds ratio 1.99, 95% confidence interval: 1.42-2.81; P < 0.001). When separated by transfer status, nonelective patients admitted as regular hospital admissions or transferred from other acute-care centres also had higher odds of suffering in-hospital mortality compared to elective admissions. Conclusions Our findings illustrate that nonelective TAVR patients are a vulnerable population that require additional medical support in the acute-care setting. As the demand for TAVR increases, further discussions regarding access to healthcare in underserved regions, the national physician shortage, and the future of the TAVR industry are imperative.
No takes yet. Share an insight, caveat, or question.
Al-Taweel et al. (2023) conducted a cohort in Aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) (n=8,778). Nonelective transcatheter aortic valve replacement (TAVR) vs. Elective transcatheter aortic valve replacement (TAVR) was evaluated on In-hospital mortality (OR 1.99, 95% CI 1.42-2.81, p=<0.001). Nonelective TAVR was associated with nearly double the odds of in-hospital mortality compared with elective TAVR.
Synapse has enriched 10 related papers. Consider them for comparative context: